Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma

INTRODUCTION: Lenalidomide (LEN) is a relatively new and very effective therapy for multiple myeloma (MM). Prior LEN therapy is associated with an increased risk of peripheral blood stem cell collection (PBSC) failure, particularly with filgrastim (G-CSF) alone. We performed a retrospective chart re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bhutani, Divaya, Zonder, Jeffrey, Valent, Jason, Tageja, Nishant, Ayash, Lois, Deol, Abhinav, Al-Kadhimi, Zaid, Abrams, Judith, Lum, Lawrence, Ratanatharathorn, Voravit, Uberti, Joseph, Abidi, Muneer H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837683/
https://ncbi.nlm.nih.gov/pubmed/23591714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-013-1808-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados